Suppliers / Zhejiang Liaoyuan Pharmaceuticals

Zhejiang Liaoyuan Pharmaceuticals

Updated 9 July 2026

Zhejiang Liaoyuan Pharmaceuticals is an API manufacturer. It holds 6 active US drug master files across a filed portfolio of 6 molecules.

6
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Apixaban US FDA 1
Clopidogrel US FDA 1
Duloxetine US FDA 1
Ferric Carboxymaltose US FDA 1
Ivabradine US FDA 1
Mirtazapine US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Liaoyuan Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability